Hashtag
The Times Real Estate

Application for clinical trial of AIM Vaccine’s human diploid rabies vaccine

An iterative process is highly effective in increasing the value of large items

HONG KONG SAR - Media OutReach Newswire - 8 November 2024 - AIM Vaccine (06660.HK), the world's second largest supplier of rabies vaccines, announced on 7th November that the application for clinical trial of the iterative-process highly-effective human diploid rabies vaccine developed by the Company has been submitted to the Center for Drug Evaluation (CDE) of National Medical Products Administration of China recently.


According to the announcement, the i iterative-process highly-effective human diploid rabies vaccine developed by AIM Vaccine shows an iterative upgrade compared to the traditional human diploid rabies vaccines of the first generation in many aspects.

The iterative-process highly-effective human diploid rabies vaccine developed by the Company has taken the lead in breaking through the technical bottlenecks of low virus titer and low yield in the traditional process. It has been optimized and innovated in the purification process with the product quality and safety significantly improved.

Compared with the number of traditional rabies vaccinations, this product developed by the Group can be vaccinated with either "five-needle approach", "simple four-needle approach" or "2-1-1 four-needle approach", which is more flexible and convenient.

There are two kinds of rabies vaccines, namely the serum-containing rabies vaccine and the serum-free rabies vaccine. However, no serum-free rabies vaccine has been registered or marketed yet. The mainstream Vero cell rabies vaccine and human diploid rabies vaccine currently available in the market are serum-containing rabies vaccines.

Compared with the traditional Vero cell rabies vaccines, human diploid rabies vaccine uses human diploid cells instead of Vero cells, which are homologous to humans and have a natural safety advantage. The human diploid rabies vaccine currently available in the market is 3 to 5 times more expensive than the Vero cell rabies vaccine, with higher product added value.

According to the announcement, AIM Vaccine has completed the construction of an iterative-process high-efficiency human diploid rabies vaccine workshop that meets international standards, and has completed the production of commercial-scale Phase III clinical trial samples, which is capable of producing this product in large scale.

China is the world's largest rabies vaccine market. According to the 2024 interim performance report of AIM Vaccine, the approved lot release volume of China's rabies vaccines increased from 58.80 million in 2019 to 78.50 million in 2021, representing an increase of 33.6%. It is expected that the market scale will increase to RMB22.0 billion by 2030, partially due to the iteration of rabies vaccine products upgrade. With the expansion of the pet market and the popularization of pre-exposure immunity knowledge, it is expected that the demand for human rabies vaccines will continue to grow in the future.
Hashtag: #AIM

The issuer is solely responsible for the content of this announcement.

Business News

PolyU and Peking University Third Hospital establish Medicine-Engineering Collaborative Innovation Research Laboratory

Opening new frontiers in smart healthcare HONG KONG SAR - Media OutReach Newswire - 23 April 2025 - The Hong Kong Polytechnic University (PolyU) and Peking University Third Hospital (PUTH) have joine...

Hashtag.net.au - avatar Hashtag.net.au

Galaxy Macau™ Teamed Up with SCMP Live to Spark Ideas and Innovation by Presenting the Capital Insights Forum

Leading Experts Gathered at GICC to Transform Wealth Strategies in a New Era for Chinese Investors MACAO SAR - Media OutReach Newswire - 23 April 2025 - Galaxy Macau™ partnered with South China Morni...

Hashtag.net.au - avatar Hashtag.net.au

Hainan fish on global tables: testament to successful Hainan Fresh Products initiative

HAIKOU, CHINA – Media OutReach Newswire – 23 April 2025 - At the 5th China International Consumer Products Expo held in Hainan recently, Wang Kangzheng, a marketing staff member of the Hainan Haiken ...

Hashtag.net.au - avatar Hashtag.net.au

ACES Awards 2025 Nominations Now Open

Singapore’s Leaders Invited to Benchmark Against Asia’s Most Rigorous Platform for Purpose-Driven Excellence SINGAPORE - Media OutReach Newswire - 24 April 2025 - In a world overflowing with accolade...

Hashtag.net.au - avatar Hashtag.net.au

CUHK Faculty of Arts Achieves Global Recognition, Consolidating Position as Leading Asian Hub for Humanities Research

HONG KONG SAR - Media OutReach Newswire - 24 April 2025 - The Faculty of Arts at The Chinese University of Hong Kong (CUHK) has made remarkable advancement in the QS World University Rankings by Sub...

Hashtag.net.au - avatar Hashtag.net.au

Octa broker wins the 'Best Proprietary Trading Platform 2025' award

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 24 April 2025 - Octa, a trusted and regulated broker founded in 2011, recently received its 10th award in 2025. This time, World Business Star Maga...

Hashtag.net.au - avatar Hashtag.net.au

Health & Wellness

Online Medical Certificate Services: Essential Features to Look Out For

Hashtag.net.au - avatar Hashtag.net.au

"Discover top online medical certificate services! Essential features to look for to get trusted and efficient results." Choosing high-quality services is essential for ensuring reliable, efficient, ...

The Importance of Having a Defibrillator in Public Spaces

Hashtag.net.au - avatar Hashtag.net.au

Life is uncertain! It is almost impossible to be 100% sure of the future, anything can happen to anyone at any time. However, in the case of Sudden Cardiac Arrests (SCA), the presence of an Automat...

Understanding Anxiety: Different Types and Treatment Options

Hashtag.net.au - avatar Hashtag.net.au

(Source) Every person experiences anxiety in some form as they face either pre-event heart palpitations before important events or constant sleep deprivation because of ongoing concerns. People exp...